Location History:
- Islip, GB (1986 - 2000)
- Islip, Oxon OX5 2SF, GB (2003)
- The Oxford Science Park, GB (2004)
- Oxon, GB (2001 - 2009)
- Oxford, GB (2006 - 2012)
Company Filing History:
16 out of 53 
3 out of 3 
3 out of 5 Years Active: 1986-2012
Title: The Innovative Legacy of Susan Mary Kingsman
Introduction:
Susan Mary Kingsman, a pioneering inventor hailing from Oxford, GB, has made significant strides in the field of immunotherapy with an impressive portfolio of 25 patents.
Latest Patents:
Among her recent patents is the groundbreaking development of peptide epitopes of the 5T4 antigen for use in immunotherapy. These epitopes play a crucial role in the diagnosis and therapy of cancer, showcasing Kingsman's dedication to advancing treatment options in oncology. Additionally, she has patented a chemo-immunotherapy method that involves administering an antigen alongside chemotherapeutic agents, opening new avenues for disease treatment and prevention.
Career Highlights:
Kingsman has left an indelible mark on renowned companies such as Oxford Biomedica (UK) Limited and Oxford Gene Systems Limited, where her innovative spirit and expertise have been instrumental in driving forward groundbreaking research and development in the medical field.
Collaborations:
Throughout her illustrious career, Susan Mary Kingsman has collaborated closely with esteemed professionals in the industry, including Alan John Kingsman and Christopher Robert Bebbington. These partnerships have fostered a culture of innovation and excellence, leading to the successful implementation of cutting-edge technologies and therapies.
Conclusion:
In conclusion, Susan Mary Kingsman's dedication to pushing the boundaries of medical innovation through her patents and collaborations underscores her invaluable contributions to the field of immunotherapy. Her work continues to inspire and pave the way for future advancements in the fight against cancer and other diseases.